Monica Niger

22PUBLICATIONS
148CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyGene and molecular therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 12, 2026
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting.

|Jul 29, 2026
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real-World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab.

|Jul 24, 2026
Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

|Jul 20, 2026
Precision Medicine in Pancreatic Cancer: Targeting KRAS and Beyond.

|Dec 30, 2025
FOLFOX Versus FOLFIRI as Second-Line Chemotherapy in Patients With Advanced Biliary Tract Cancers: A Multicenter, Italian Study.

Chiara Pircher, Federico Nichetti, Mario Domenico Rizzato

|Nov 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.

Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda

Pageof 4

Frequent Collaborators

7 joint publications

Federico Nichetti

6 joint publications

Margherita Rimini

6 joint publications

Filippo Pietrantonio

5 joint publications

Caterina Vivaldi